Brain high-throughput multi-omics data reveal molecular heterogeneity in Alzheimer’s disease
Open accessThe DOI matches its Crossref record; 187 of the 187 references it cites were found in a registry or an index.
Abstract
Unbiased data-driven omic approaches are revealing the molecular heterogeneity of Alzheimer disease. Here, we used machine learning approaches to integrate high-throughput transcriptomic, proteomic, metabolomic, and lipidomic profiles with clinical and neuropathological data from multiple human AD cohorts. We discovered 4 unique multimodal molecular profiles, one of them showing signs of poor cognitive function, a faster pace of disease progression, shorter survival with the disease, severe neurodegeneration and astrogliosis, and reduced levels of metabolomic profiles. We found this molecular profile to be present in multiple affected cortical regions associated with higher Braak tau scores and significant dysregulation of synapse-related genes, endocytosis, phagosome, and mTOR signaling pathways altered in AD early and late stages. AD cross-omics data integration with transcriptomic data from an SNCA mouse model revealed an overlapping signature. Furthermore, we leveraged single-nuclei RNA-seq data to identify distinct cell-types that most likely mediate molecular profiles. Lastly, we identified that the multimodal clusters uncovered cerebrospinal fluid biomarkers poised to monitor AD progression and possibly cognition. Our cross-omics analyses provide novel critical molecular insights into AD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



![Fig 4 The parietal cortex of participants with worse cognitive function exhibited remarkable molecular dysregulation. (A) Bar plots showing the significant genes detected in each cluster compared to the control. Yellow represents the total number of genes, green represents the cluster-specific genes, and purple depicts the number of genes missed with an unclustered approach (all AD cases vs. control). (B) Same as panel “A” but for proteins. (C) Same as panel “A” but for metabolites. (D) Race track plot showing the percentage of significant features for each cluster compared to other clusters for the 3 omics. (E) Venn diagrams showing the overlap between significant genes in Knight-C4 and synaptic genes (“synaptosome”) from Fei and colleagues [46]. (F) Same as “E” but overlaps with SynGO dataset [47]. The significance of overlap was computed using Fisher’s exact test. (G) Top 20 KEGG pathways associated with Knight-C4. (H) Top 20 GO biological process pathways associated with Knight-C4. The data underlying panels A, B, and C can be found in S1 Data. AD, Alzheimer disease.](https://figures.cochat.ai/paper-figures/d7d9ccfe3a3549c0934558fd322d14fb/brain-high-throughput-multi-omics-data-reveal-molecular-heterogeneity-in-figure-4.jpg)





Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Multimodal fusion may eventually support individualized signatures, but current evidence does not yet justify real-time clinical course correction or routine biomarker-guided antidepressant switching [405,406] (Figure 4).”
From Synaptic Plasticity—Intrinsic Excitability and Antidepressant Discovery (2026) · cites this paper as [405]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“To investigate these alterations, machine learning techniques have been employed to integrate transcriptomic and proteomic datasets, revealing widespread dysregulation within neurotrophic signaling networks in AD41,58.”
From Artificial intelligence-driven multi-omics approaches in Alzheimer's disease: Progress, challenges, and future directions (2025) · cites this paper as [58]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“This integrative analysis revealed molecular subtypes of AD that correlated with neuropathological severity and cognitive decline, implicating key biological pathways including endocytosis and cholesterol metabolism58.”
From Artificial intelligence-driven multi-omics approaches in Alzheimer's disease: Progress, challenges, and future directions (2025) · cites this paper as [58]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“High-throughput transcriptomic and proteomic studies have delineated at least four molecular subtypes of AD, each characterized by distinct immune, metabolic, and inflammatory signatures that correlate with clinical trajectories58.”
From Artificial intelligence-driven multi-omics approaches in Alzheimer's disease: Progress, challenges, and future directions (2025) · cites this paper as [58]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Single-cell multi-omics has further refined biomarker discovery by enabling cell-type and cell-state-specific resolution, though this granularity increases the computational burden and necessitates improved harmonization protocols58.”
From Artificial intelligence-driven multi-omics approaches in Alzheimer's disease: Progress, challenges, and future directions (2025) · cites this paper as [58]
Experimental — accuracy not yet measured
3 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
R: A Language and Environment for Statistical Computing
R Core Team (2025) · doi:10.32614/r.manuals · Cited by 352,181
Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing
Benjamini, Y., & Hochberg, Y. (1995) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1995.tb02031.x · Cited by 109,482
Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2
Love, M. I., Huber, W., & Anders, S. (2014) · Genome Biology · doi:10.1186/s13059-014-0550-8 · Cited by 95,106
STAR: ultrafast universal RNA-seq aligner
Dobin, A., Davis, C. A., Schlesinger, F., Drenkow, J., Zaleski, C., Jha, S., Batut, P., Chaisson, M., & Gingeras, T. R. (2013) · Bioinformatics · doi:10.1093/bioinformatics/bts635 · Cited by 51,709
WGCNA: an R package for weighted correlation network analysis
Langfelder, P., & Horvath, S. (2008) · BMC Bioinformatics · doi:10.1186/1471-2105-9-559 · Cited by 27,252
Repertoires of Autophagy in the Pathogenesis of Ocular Diseases
Li, Y.-J., Jiang, Q., Cao, G.-F., Yao, J., & Yan, B. (2015) · Cellular Physiology and Biochemistry · doi:10.1159/000373980 · Cited by 16,304
FactoMineR : An R Package for Multivariate Analysis
Lê, S., Josse, J., & Husson, F. (2008) · Journal of Statistical Software · doi:10.18637/jss.v025.i01 · Cited by 11,603
Shrestha, S., & Offer, S. M. (2016) · Medical Epigenetics · doi:10.1159/000444713 · Cited by 8,914
Spillantini, M. G., Schmidt, M. L., Lee, V. M.-Y., Trojanowski, J. Q., Jakes, R., & Goedert, M. (1997) · Nature · doi:10.1038/42166 · Cited by 8,382
Mutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease
Polymeropoulos, M. H., Lavedan, C., Leroy, E., Ide, S. E., Dehejia, A., Dutra, A., Pike, B., Root, H., Rubenstein, J., Boyer, R., et al. (1997) · Science · doi:10.1126/science.276.5321.2045 · Cited by 8,240
Massively parallel digital transcriptional profiling of single cells
Zheng, G. X. Y., Terry, J. M., Belgrader, P., Ryvkin, P., Bent, Z. W., Wilson, R., Ziraldo, S. B., Wheeler, T. D., McDermott, G. P., Zhu, J., et al. (2017) · Nature Communications · doi:10.1038/ncomms14049 · Cited by 7,353
Comprehensive molecular characterization of gastric adenocarcinoma
The Cancer Genome Atlas Research Network (2014) · Nature · doi:10.1038/nature13480 · Cited by 6,498
Leek, J. T., Johnson, W. E., Parker, H. S., Jaffe, A. E., & Storey, J. D. (2012) · Bioinformatics · doi:10.1093/bioinformatics/bts034 · Cited by 6,231
Integrated genomic characterization of endometrial carcinoma
The Cancer Genome Atlas Research Network, & Levine, D. A. (2013) · Nature · doi:10.1038/nature12113 · Cited by 5,784
Comprehensive molecular profiling of lung adenocarcinoma
The Cancer Genome Atlas Research Network (2014) · Nature · doi:10.1038/nature13385 · Cited by 5,732
Cui, C., Cui, J., Jin, F., Cui, Y., Li, R., Jiang, X., Tian, Y., Wang, K., Jiang, P., & Gao, J. (2017) · Cellular Physiology and Biochemistry · doi:10.1159/000479571 · Cited by 5,203
Warde-Farley, D., Donaldson, S. L., Comes, O., Zuberi, K., Badrawi, R., Chao, P., Franz, M., Grouios, C., Kazi, F., Lopes, C. T., et al. (2010) · Nucleic Acids Research · doi:10.1093/nar/gkq537 · Cited by 4,835
α-Synuclein Locus Triplication Causes Parkinson's Disease
Singleton, A. B., Farrer, M., Johnson, J., Singleton, A., Hague, S., Kachergus, J., Hulihan, M., Peuralinna, T., Dutra, A., Nussbaum, R., et al. (2003) · Science · doi:10.1126/science.1090278 · Cited by 4,383
Comprehensive genomic characterization of squamous cell lung cancers
The Cancer Genome Atlas Research Network (2012) · Nature · doi:10.1038/nature11404 · Cited by 3,994
MetaboAnalyst 5.0: narrowing the gap between raw spectra and functional insights
Pang, Z., Chong, J., Zhou, G., de Lima Morais, D. A., Chang, L., Barrette, M., Gauthier, C., Jacques, P.-É., Li, S., & Xia, J. (2021) · Nucleic Acids Research · doi:10.1093/nar/gkab382 · Cited by 3,958
Harold, D., Abraham, R., Hollingworth, P., Sims, R., Gerrish, A., Hamshere, M. L., Pahwa, J. S., Moskvina, V., Dowzell, K., Williams, A., et al. (2009) · Nature Genetics · doi:10.1038/ng.440 · Cited by 3,326
Self-citationLuk, K. C., Kehm, V., Carroll, J., Zhang, B., O’Brien, P., Trojanowski, J. Q., & Lee, V. M.-Y. (2012) · Science · doi:10.1126/science.1227157 · Cited by 2,563
Südhof, T. C. (2004) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.26.041002.131412 · Cited by 2,547
Comprehensive and Integrative Genomic Characterization of Hepatocellular Carcinoma
Ally, A., Balasundaram, M., Carlsen, R., Chuah, E., Clarke, A., Dhalla, N., Holt, R. A., Jones, S. J. M., Lee, D., Ma, Y., et al. (2017) · Cell · doi:10.1016/j.cell.2017.05.046 · Cited by 2,490
Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease
the European Alzheimer's Disease Initiative Investigators, Lambert, J.-C., Heath, S., Even, G., Campion, D., Sleegers, K., Hiltunen, M., Combarros, O., Zelenika, D., Bullido, M. J., et al. (2009) · Nature Genetics · doi:10.1038/ng.439 · Cited by 2,234
The role of autophagy in neurodegenerative disease
Nixon, R. A. (2013) · Nature Medicine · doi:10.1038/nm.3232 · Cited by 2,059
Masliah, E., Rockenstein, E., Veinbergs, I., Mallory, M., Hashimoto, M., Takeda, A., Sagara, Y., Sisk, A., & Mucke, L. (2000) · Science · doi:10.1126/science.287.5456.1265 · Cited by 1,765
Aptamer-Based Multiplexed Proteomic Technology for Biomarker Discovery
Gold, L., Ayers, D., Bertino, J., Bock, C., Bock, A., Brody, E. N., Carter, J., Dalby, A. B., Eaton, B. E., Fitzwater, T., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0015004 · Cited by 1,754
Tryptophan metabolism as a common therapeutic target in cancer, neurodegeneration and beyond
Platten, M., Nollen, E. A. A., Röhrig, U. F., Fallarino, F., & Opitz, C. A. (2019) · Nature Reviews Drug Discovery · doi:10.1038/s41573-019-0016-5 · Cited by 1,586
Volpicelli-Daley, L. A., Luk, K. C., Patel, T. P., Tanik, S. A., Riddle, D. M., Stieber, A., Meaney, D. F., Trojanowski, J. Q., & Lee, V. M.-Y. (2011) · Neuron · doi:10.1016/j.neuron.2011.08.033 · Cited by 1,569
Neuronal α-Synucleinopathy with Severe Movement Disorder in Mice Expressing A53T Human α-Synuclein
Giasson, B. I., Duda, J. E., Quinn, S. M., Zhang, B., Trojanowski, J. Q., & Lee, V. M.-Y. (2002) · Neuron · doi:10.1016/s0896-6273(02)00682-7 · Cited by 1,266
Zhou, Y., Song, W. M., Andhey, P. S., Swain, A., Levy, T., Miller, K. R., Poliani, P. L., Cominelli, M., Grover, S., Gilfillan, S., et al. (2020) · Nature Medicine · doi:10.1038/s41591-019-0695-9 · Cited by 1,150
Endocannabinoid Signaling and Synaptic Function
Castillo, P. E., Younts, T. J., Chávez, A. E., & Hashimotodani, Y. (2012) · Neuron · doi:10.1016/j.neuron.2012.09.020 · Cited by 1,120
Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas
Abeshouse, A., Adebamowo, C., Adebamowo, S. N., Akbani, R., Akeredolu, T., Ally, A., Anderson, M. L., Anur, P., Appelbaum, E. L., Armenia, J., et al. (2017) · Cell · doi:10.1016/j.cell.2017.10.014 · Cited by 1,069
Yeh, F. L., Wang, Y., Tom, I., Gonzalez, L. C., & Sheng, M. (2016) · Neuron · doi:10.1016/j.neuron.2016.06.015 · Cited by 943
SynGO: An Evidence-Based, Expert-Curated Knowledge Base for the Synapse
Koopmans, F., van Nierop, P., Andres-Alonso, M., Byrnes, A., Cijsouw, T., Coba, M. P., Cornelisse, L. N., Farrell, R. J., Goldschmidt, H. L., Howrigan, D. P., et al. (2019) · Neuron · doi:10.1016/j.neuron.2019.05.002 · Cited by 938
Lee, M. K., Stirling, W., Xu, Y., Xu, X., Qui, D., Mandir, A. S., Dawson, T. M., Copeland, N. G., Jenkins, N. A., & Price, D. L. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.132197599 · Cited by 824
Blood GFAP as an emerging biomarker in brain and spinal cord disorders
Abdelhak, A., Foschi, M., Abu-Rumeileh, S., Yue, J. K., D’Anna, L., Huss, A., Oeckl, P., Ludolph, A. C., Kuhle, J., Petzold, A., et al. (2022) · Nature Reviews Neurology · doi:10.1038/s41582-021-00616-3 · Cited by 807
Hamilton, R. L. (2000) · Brain Pathology · doi:10.1111/j.1750-3639.2000.tb00269.x · Cited by 754
Four distinct trajectories of tau deposition identified in Alzheimer’s disease
Initiative, T. A. D. N., Vogel, J. W., Young, A. L., Oxtoby, N. P., Smith, R., Ossenkoppele, R., Strandberg, O. T., La Joie, R., Aksman, L. M., Grothe, M. J., et al. (2021) · Nature Medicine · doi:10.1038/s41591-021-01309-6 · Cited by 741
Overview and Findings from the Religious Orders Study
A. Bennett, D., A. Schneider, J., Arvanitakis, Z., & S. Wilson, R. (2012) · Current Alzheimer Research · doi:10.2174/156720512801322573 · Cited by 672
Herpes simplex virus type 1 in brain and risk of Alzheimer's disease
Itzhaki, R. F., Lin, W.-R., Shang, D., Wilcock, G. K., Faragher, B., & Jamieson, G. A. (1997) · The Lancet · doi:10.1016/s0140-6736(96)10149-5 · Cited by 669
Young, A. L., Marinescu, R. V., Oxtoby, N. P., Bocchetta, M., Yong, K., Firth, N. C., Cash, D. M., Thomas, D. L., Dick, K. M., Cardoso, J., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-05892-0 · Cited by 596
Self-citationHansson, O., Lehmann, S., Otto, M., Zetterberg, H., & Lewczuk, P. (2019) · Alzheimer's Research & Therapy · doi:10.1186/s13195-019-0485-0 · Cited by 585
Deep Multilayer Brain Proteomics Identifies Molecular Networks in Alzheimer’s Disease Progression
Bai, B., Wang, X., Li, Y., Chen, P.-C., Yu, K., Dey, K. K., Yarbro, J. M., Han, X., Lutz, B. M., Rao, S., et al. (2020) · Neuron · doi:10.1016/j.neuron.2019.12.015 · Cited by 565
Johnson, E. C. B., Carter, E. K., Dammer, E. B., Duong, D. M., Gerasimov, E. S., Liu, Y., Liu, J., Betarbet, R., Ping, L., Yin, L., et al. (2022) · Nature Neuroscience · doi:10.1038/s41593-021-00999-y · Cited by 561
GABA as an inhibitory neurotransmitter in human cerebral cortex
McCormick, D. A. (1989) · Journal of Neurophysiology · doi:10.1152/jn.1989.62.5.1018 · Cited by 557
Lippa, C. F., Fujiwara, H., Mann, D. M. A., Giasson, B., Baba, M., Schmidt, M. L., Nee, L. E., O'Connell, B., Pollen, D. A., St. George-Hyslop, P., et al. (1998) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65722-7 · Cited by 533
Deregulation of sphingolipid metabolism in Alzheimer’s disease
He, X., Huang, Y., Li, B., Gong, C.-X., & Schuchman, E. H. (2010) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2008.05.010 · Cited by 516
Nobili, A., Latagliata, E. C., Viscomi, M. T., Cavallucci, V., Cutuli, D., Giacovazzo, G., Krashia, P., Rizzo, F. R., Marino, R., Federici, M., et al. (2017) · Nature Communications · doi:10.1038/ncomms14727 · Cited by 514
Evidence for brain glucose dysregulation in Alzheimer's disease
An, Y., Varma, V. R., Varma, S., Casanova, R., Dammer, E., Pletnikova, O., Chia, C. W., Egan, J. M., Ferrucci, L., Troncoso, J., et al. (2018) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2017.09.011 · Cited by 507
Wang, M., Beckmann, N. D., Roussos, P., Wang, E., Zhou, X., Wang, Q., Ming, C., Neff, R., Ma, W., Fullard, J. F., et al. (2018) · Scientific Data · doi:10.1038/sdata.2018.185 · Cited by 502
Metabolic network failures in Alzheimer's disease: A biochemical road map
Toledo, J. B., Arnold, M., Kastenmüller, G., Chang, R., Baillie, R. A., Han, X., Thambisetty, M., Tenenbaum, J. D., Suhre, K., Thompson, J. W., et al. (2017) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2017.01.020 · Cited by 468
Herpes simplex virus type 1 DNA is located within Alzheimer's disease amyloid plaques
Wozniak, M., Mee, A., & Itzhaki, R. (2009) · The Journal of Pathology · doi:10.1002/path.2449 · Cited by 464
ApoE and Clusterin Cooperatively Suppress Aβ Levels and Deposition
DeMattos, R. B., Cirrito, J. R., Parsadanian, M., May, P. C., O'Dell, M. A., Taylor, J. W., Harmony, J. A. K., Aronow, B. J., Bales, K. R., Paul, S. M., et al. (2004) · Neuron · doi:10.1016/s0896-6273(03)00850-x · Cited by 459
Chatterjee, P., Pedrini, S., Stoops, E., Goozee, K., Villemagne, V. L., Asih, P. R., Verberk, I. M. W., Dave, P., Taddei, K., Sohrabi, H. R., et al. (2021) · Translational Psychiatry · doi:10.1038/s41398-020-01137-1 · Cited by 439
Biological subtypes of Alzheimer disease: A systematic review and meta-analysis
Ferreira, D., Nordberg, A., & Westman, E. (2020) · Neurology · doi:10.1212/wnl.0000000000009058 · Cited by 422
Whitwell, J. L., Dickson, D. W., Murray, M. E., Weigand, S. D., Tosakulwong, N., Senjem, M. L., Knopman, D. S., Boeve, B. F., Parisi, J. E., Petersen, R. C., et al. (2012) · The Lancet Neurology · doi:10.1016/s1474-4422(12)70200-4 · Cited by 419
A clinicopathological approach to the diagnosis of dementia
Elahi, F. M., & Miller, B. L. (2017) · Nature Reviews Neurology · doi:10.1038/nrneurol.2017.96 · Cited by 412
Sosna, J., Philipp, S., Albay, R., Reyes-Ruiz, J. M., Baglietto-Vargas, D., LaFerla, F. M., & Glabe, C. G. (2018) · Molecular Neurodegeneration · doi:10.1186/s13024-018-0244-x · Cited by 406
Clusterin in Alzheimer’s Disease: Mechanisms, Genetics, and Lessons From Other Pathologies
Foster, E. M., Dangla-Valls, A., Lovestone, S., Ribe, E. M., & Buckley, N. J. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00164 · Cited by 381
Nativio, R., Lan, Y., Donahue, G., Sidoli, S., Berson, A., Srinivasan, A. R., Shcherbakova, O., Amlie-Wolf, A., Nie, J., Cui, X., et al. (2020) · Nature Genetics · doi:10.1038/s41588-020-0696-0 · Cited by 380
Oeckl, P., Halbgebauer, S., Anderl-Straub, S., Steinacker, P., Huss, A. M., Neugebauer, H., von Arnim, C. A. F., Diehl-Schmid, J., Grimmer, T., Kornhuber, J., et al. (2019) · Journal of Alzheimer’s Disease · doi:10.3233/jad-180325 · Cited by 345
Dube, U., Del-Aguila, J. L., Li, Z., Budde, J. P., Jiang, S., Hsu, S., Ibanez, L., Fernandez, M. V., Farias, F., Norton, J., et al. (2019) · Nature Neuroscience · doi:10.1038/s41593-019-0501-5 · Cited by 345
Self-citationAutophagy and Alzheimer’s Disease
Li, Q., Liu, Y., & Sun, M. (2017) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-016-0386-8 · Cited by 330
Neff, R. A., Wang, M., Vatansever, S., Guo, L., Ming, C., Wang, Q., Wang, E., Horgusluoglu-Moloch, E., Song, W.-M., Li, A., et al. (2021) · Science Advances · doi:10.1126/sciadv.abb5398 · Cited by 324
Cicognola, C., Janelidze, S., Hertze, J., Zetterberg, H., Blennow, K., Mattsson-Carlgren, N., & Hansson, O. (2021) · Alzheimer's Research & Therapy · doi:10.1186/s13195-021-00804-9 · Cited by 300
Brinkmalm, A., Brinkmalm, G., Honer, W. G., Frölich, L., Hausner, L., Minthon, L., Hansson, O., Wallin, A., Zetterberg, H., Blennow, K., et al. (2014) · Molecular Neurodegeneration · doi:10.1186/1750-1326-9-53 · Cited by 293
α-Synuclein pathology in Parkinson’s disease and related α-synucleinopathies
Henderson, M. X., Trojanowski, J. Q., & Lee, V. M.-Y. (2019) · Neuroscience Letters · doi:10.1016/j.neulet.2019.134316 · Cited by 291
Yang, C., Farias, F. H. G., Ibanez, L., Suhy, A., Sadler, B., Fernandez, M. V., Wang, F., Bradley, J. L., Eiffert, B., Bahena, J. A., et al. (2021) · Nature Neuroscience · doi:10.1038/s41593-021-00886-6 · Cited by 290
Self-citationA fully Bayesian latent variable model for integrative clustering analysis of multi-type omics data
Mo, Q., Shen, R., Guo, C., Vannucci, M., Chan, K. S., & Hilsenbeck, S. G. (2018) · Biostatistics · doi:10.1093/biostatistics/kxx017 · Cited by 280
Potential roles of insulin and IGF-1 in Alzheimer's disease
Gasparini, L., & Xu, H. (2003) · Trends in Neurosciences · doi:10.1016/s0166-2236(03)00163-2 · Cited by 276
“Is dopamine involved in Alzheimer's disease?â€
Martorana, A., & Koch, G. (2014) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2014.00252 · Cited by 275
Neural Activity Controls the Synaptic Accumulation of α-Synuclein
Fortin, D. L., Nemani, V. M., Voglmaier, S. M., Anthony, M. D., Ryan, T. A., & Edwards, R. H. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.2922-05.2005 · Cited by 271
Architecture of the Mouse Brain Synaptome
Zhu, F., Cizeron, M., Qiu, Z., Benavides-Piccione, R., Kopanitsa, M. V., Skene, N. G., Koniaris, B., DeFelipe, J., Fransén, E., Komiyama, N. H., et al. (2018) · Neuron · doi:10.1016/j.neuron.2018.07.007 · Cited by 271
The Synaptic Vesicle Cycle Revisited: New Insights into the Modes and Mechanisms
Chanaday, N. L., Cousin, M. A., Milosevic, I., Watanabe, S., & Morgan, J. R. (2019) · The Journal of Neuroscience · doi:10.1523/jneurosci.1158-19.2019 · Cited by 255
Sobue, A., Komine, O., Hara, Y., Endo, F., Mizoguchi, H., Watanabe, S., Murayama, S., Saito, T., Saido, T. C., Sahara, N., et al. (2021) · Acta Neuropathologica Communications · doi:10.1186/s40478-020-01099-x · Cited by 253
Bassil, F., Brown, H. J., Pattabhiraman, S., Iwasyk, J. E., Maghames, C. M., Meymand, E. S., Cox, T. O., Riddle, D. M., Zhang, B., Trojanowski, J. Q., et al. (2020) · Neuron · doi:10.1016/j.neuron.2019.10.010 · Cited by 247
A 3D human brain–like tissue model of herpes-induced Alzheimer’s disease
Cairns, D. M., Rouleau, N., Parker, R. N., Walsh, K. G., Gehrke, L., & Kaplan, D. L. (2020) · Science Advances · doi:10.1126/sciadv.aay8828 · Cited by 247
Root, J., Merino, P., Nuckols, A., Johnson, M., & Kukar, T. (2021) · Neurobiology of Disease · doi:10.1016/j.nbd.2021.105360 · Cited by 238
Metabolic Dysregulation Contributes to the Progression of Alzheimer’s Disease
Yan, X., Hu, Y., Wang, B., Wang, S., & Zhang, X. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.530219 · Cited by 220
Axonal BACE1 dynamics and targeting in hippocampal neurons: a role for Rab11 GTPase
Buggia-Prévot, V., Fernandez, C. G., Riordan, S., Vetrivel, K. S., Roseman, J., Waters, J., Bindokas, V. P., Vassar, R., & Thinakaran, G. (2014) · Molecular Neurodegeneration · doi:10.1186/1750-1326-9-1 · Cited by 214
Imaging the progression of Alzheimer pathology through the brain
Smith, A. D. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.082107399 · Cited by 206
Autophagy in Alzheimer’s disease
Zare-shahabadi, A., Masliah, E., Johnson, G. V. W., & Rezaei, N. (2015) · Reviews in the Neurosciences · doi:10.1515/revneuro-2014-0076 · Cited by 204
Sex and APOE ε4 genotype modify the Alzheimer’s disease serum metabolome
Arnold, M., Nho, K., Kueider-Paisley, A., Massaro, T., Huynh, K., Brauner, B., MahmoudianDehkordi, S., Louie, G., Moseley, M. A., Thompson, J. W., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-14959-w · Cited by 202
Itzhaki, R. F. (2014) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2014.00202 · Cited by 199
Autophagic/lysosomal dysfunction in Alzheimer’s disease
Orr, M. E., & Oddo, S. (2013) · Alzheimer's Research & Therapy · doi:10.1186/alzrt217 · Cited by 199
CellMix: a comprehensive toolbox for gene expression deconvolution
Gaujoux, R., & Seoighe, C. (2013) · Bioinformatics · doi:10.1093/bioinformatics/btt351 · Cited by 192
Pathophysiological subtypes of Alzheimer’s disease based on cerebrospinal fluid proteomics
Tijms, B. M., Gobom, J., Reus, L., Jansen, I., Hong, S., Dobricic, V., Kilpert, F., ten Kate, M., Barkhof, F., Tsolaki, M., et al. (2020) · Brain · doi:10.1093/brain/awaa325 · Cited by 192
Duarte, L. F., Farías, M. A., Álvarez, D. M., Bueno, S. M., Riedel, C. A., & González, P. A. (2019) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2019.00046 · Cited by 183
A single-nuclei RNA sequencing study of Mendelian and sporadic AD in the human brain
Del-Aguila, J. L., Li, Z., Dube, U., Mihindukulasuriya, K. A., Budde, J. P., Fernandez, M. V., Ibanez, L., Bradley, J., Wang, F., Bergmann, K., et al. (2019) · Alzheimer's Research & Therapy · doi:10.1186/s13195-019-0524-x · Cited by 183
Self-citationJiménez-Balado, J., & Eich, T. S. (2021) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2021.01.005 · Cited by 183
Alzheimer’s disease: Targeting the glutamatergic system
Conway, M. E. (2020) · Biogerontology · doi:10.1007/s10522-020-09860-4 · Cited by 180
The lysosome and neurodegenerative diseases
Zhang, L., Sheng, R., & Qin, Z. (2009) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gmp031 · Cited by 177
APOE genotype regulates pathology and disease progression in synucleinopathy
Davis, A. A., Inman, C. E., Wargel, Z. M., Dube, U., Freeberg, B. M., Galluppi, A., Haines, J. N., Dhavale, D. D., Miller, R., Choudhury, F. A., et al. (2020) · Science Translational Medicine · doi:10.1126/scitranslmed.aay3069 · Cited by 177
Self-citationAstrogliosis as a therapeutic target for neurodegenerative diseases
Colangelo, A. M., Alberghina, L., & Papa, M. (2014) · Neuroscience Letters · doi:10.1016/j.neulet.2014.01.014 · Cited by 176
Arai, Y., Yamazaki, M., Mori, O., Muramatsu, H., Asano, G., & Katayama, Y. (2001) · Brain Research · doi:10.1016/s0006-8993(00)03082-1 · Cited by 173
Approaches to Integrating Metabolomics and Multi-Omics Data: A Primer
Jendoubi, T. (2021) · Metabolites · doi:10.3390/metabo11030184 · Cited by 173
CSF biomarkers of neuroinflammation in distinct forms and subtypes of neurodegenerative dementia
Abu‐Rumeileh, S., Steinacker, P., Polischi, B., Mammana, A., Bartoletti‐Stella, A., Oeckl, P., Baiardi, S., Zenesini, C., Huss, A. M., Cortelli, P., et al. (2019) · Alzheimer s Research & Therapy · doi:10.1186/s13195-019-0562-4 · Cited by 170
Dopaminergic Modulation of Cortical Plasticity in Alzheimer’s Disease Patients
Koch, G., Lorenzo, F. D., Bonnì, S., Giacobbe, V., Bozzali, M., Caltagirone, C., & Martorana, A. (2014) · Neuropsychopharmacology · doi:10.1038/npp.2014.119 · Cited by 162
Bukke, V. N., Archana, M., Villani, R., Romano, A. D., Wawrzyniak, A., Balawender, K., Orkisz, S., Beggiato, S., Serviddio, G., & Cassano, T. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21207452 · Cited by 161
Alzheimer’s Disease Pathogenesis: Role of Autophagy and Mitophagy Focusing in Microglia
Eshraghi, M., Adlimoghaddam, A., Mahmoodzadeh, A., Sharifzad, F., Yasavoli-Sharahi, H., Lorzadeh, S., Albensi, B. C., & Ghavami, S. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22073330 · Cited by 158
Ishiki, A., Kamada, M., Kawamura, Y., Terao, C., Shimoda, F., Tomita, N., Arai, H., & Furukawa, K. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13399 · Cited by 156
Omics sciences for systems biology in Alzheimer’s disease: State-of-the-art of the evidence
Hampel, H. J., Nisticò, R., Seyfried, N. T., Levey, A. I., Modeste, E. S., Lemercier, P., Baldacci, F., Toschi, N., Garaci, F., Perry, G. L., et al. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101346 · Cited by 153
Extracellular α-synuclein levels are regulated by neuronal activity
Yamada, K., & Iwatsubo, T. (2018) · Molecular Neurodegeneration · doi:10.1186/s13024-018-0241-0 · Cited by 148
Targeting the mTOR Signaling Network for Alzheimer’s Disease Therapy
Wang, C., Yu, J., Miao, D., Wu, Z., Tan, M., & Tan, L. (2013) · Molecular Neurobiology · doi:10.1007/s12035-013-8505-8 · Cited by 142
Cell “Self‐Eating” (Autophagy) Mechanism in Alzheimer's Disease
Funderburk, S. F., Marcellino, B. K., & Yue, Z. (2010) · Mount Sinai Journal of Medicine: A Journal of Translational and Personalized Medicine · doi:10.1002/msj.20161 · Cited by 139
Semi-supervised Nonnegative Matrix Factorization for gene expression deconvolution: A case study
Gaujoux, R., & Seoighe, C. (2011) · Infection Genetics and Evolution · doi:10.1016/j.meegid.2011.08.014 · Cited by 139
Regional Distribution of α-Synuclein Pathology in Unimpaired Aging and Alzheimer Disease
Parkkinen, L., Soininen, H., & Alafuzoff, I. (2003) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/62.4.363 · Cited by 129
Guzmán-Ramos, K., Moreno-Castilla, P., Castro-Cruz, M., McGaugh, J. L., Martínez-Coria, H., LaFerla, F. M., & Bermúdez-Rattoni, F. (2012) · Learning & Memory · doi:10.1101/lm.026070.112 · Cited by 127
Dysregulation of protein trafficking in neurodegeneration
Wang, X., Huang, T., Bu, G., & Xu, H. (2014) · Molecular Neurodegeneration · doi:10.1186/1750-1326-9-31 · Cited by 125
Cohn, W., Melnik, M., Huang, C., Teter, B., Chandra, S., Zhu, C., McIntire, L. B., John, V., Gylys, K. H., & Bilousova, T. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.766082 · Cited by 122
Clark, C., Dayon, L., Masoodi, M., Bowman, G. L., & Popp, J. (2021) · Alzheimer s Research & Therapy · doi:10.1186/s13195-021-00814-7 · Cited by 122
Sparse integrative clustering of multiple omics data sets
Shen, R., Wang, S., & Mo, Q. (2013) · The Annals of Applied Statistics · doi:10.1214/12-aoas578 · Cited by 121
Jesse, S., Steinacker, P., Cepek, L., Arnim, C. A. F. V., Tumani, H., Lehnert, S., Kretzschmar, H. A., Baier, M., & Otto, M. (2009) · Journal of Alzheimer s Disease · doi:10.3233/jad-2009-1075 · Cited by 119
Byun, M. S., Kim, S. E., Park, J., Yi, D., Choe, Y. M., Sohn, B. K., Choi, H. J., Baek, H., Han, J. Y., Woo, J. I., et al. (2015) · PLOS ONE · doi:10.1371/journal.pone.0142756 · Cited by 118
Levodopa ameliorates learning and memory deficits in a murine model of Alzheimer’s disease
Ambrée, O., Richter, H., Sachser, N., Lewejohann, L., Dere, E., de Souza Silva, M. A., Herring, A., Keyvani, K., Paulus, W., & Schäbitz, W.-R. (2009) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2007.11.010 · Cited by 115
40 YEARS of IGF1: IGF1: the Jekyll and Hyde of the aging brain
Gubbi, S., Quipildor, G. F., Barzilai, N., Huffman, D. M., & Milman, S. (2018) · Journal of Molecular Endocrinology · doi:10.1530/jme-18-0093 · Cited by 115
α-Synuclein modulates tau spreading in mouse brains
Bassil, F., Meymand, E. S., Brown, H. J., Xu, H. W., Cox, T. O., Pattabhiraman, S., Maghames, C. M., Wu, Q., Zhang, B., Trojanowski, J. Q., et al. (2020) · The Journal of Experimental Medicine · doi:10.1084/jem.20192193 · Cited by 114
Alzheimer's disease in the omics era
Sancesario, G. M., & Bernardini, S. (2018) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2018.06.011 · Cited by 113
Puntambekar, S. S., Moutinho, M., Lin, P. B.-C., Jadhav, V., Tumbleson-Brink, D., Balaji, A., Benito, M. A., Xu, G., Oblak, A., Lasagna-Reeves, C. A., et al. (2022) · Molecular Neurodegeneration · doi:10.1186/s13024-022-00545-9 · Cited by 113
Glucose metabolism and AD: evidence for a potential diabetes type 3
González, A., Calfío, C., Churruca, M., & Maccioni, R. B. (2022) · Alzheimer's Research & Therapy · doi:10.1186/s13195-022-00996-8 · Cited by 112
Ou, Y., Yang, Y., Deng, Y., Zhang, C. M., Hu, H., Wu, B., Liu, Y., Wang, Y., Zhu, Y., Suckling, J., et al. (2021) · Molecular Psychiatry · doi:10.1038/s41380-021-01251-6 · Cited by 111
Protective Effects of Positive Lysosomal Modulation in Alzheimer's Disease Transgenic Mouse Models
Butler, D., Hwang, J., Estick, C., Nishiyama, A., Kumar, S. S., Baveghems, C. L., Young-Oxendine, H. B., Wisniewski, M. L., Charalambides, A., & Bahr, B. A. (2011) · PLoS ONE · doi:10.1371/journal.pone.0020501 · Cited by 102
Iturria-Medina, Y., Adewale, Q., Khan, A. F., Ducharme, S., Rosa-Neto, P., O’Donnell, K., Petyuk, V. A., Gauthier, S., De Jager, P. L., Breitner, J., et al. (2022) · Science Advances · doi:10.1126/sciadv.abo6764 · Cited by 100
Single-nucleus RNA-sequencing of autosomal dominant Alzheimer disease and risk variant carriers
Brase, L., You, S.-F., D’Oliveira Albanus, R., Del-Aguila, J. L., Dai, Y., Novotny, B. C., Soriano-Tarraga, C., Dykstra, T., Fernandez, M. V., Budde, J. P., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-37437-5 · Cited by 98
Self-citationHulette, C., Mirra, S., Wilkinson, W., Heyman, A., Fillenbaum, G., & Clark, C. (1995) · Neurology · doi:10.1212/wnl.45.11.1991 · Cited by 98
[18F]AV‐1451 clustering of entorhinal and cortical uptake in Alzheimer's disease
Whitwell, J. L., Graff‐Radford, J., Tosakulwong, N., Weigand, S. D., Machulda, M., Senjem, M. L., Schwarz, C. G., Spychalla, A. J., Jones, D. T., Drubach, D. A., et al. (2018) · Annals of Neurology · doi:10.1002/ana.25142 · Cited by 97
Erdman, J. W., Oria, M. P., & Pillsbury, L. (2011) · Cited by 96
The landscape of metabolic brain alterations in Alzheimer's disease
Batra, R., Arnold, M., Wörheide, M. A., Allen, M., Wang, X., Blach, C., Levey, A. I., Seyfried, N. T., Ertekin‐Taner, N., Bennett, D. A., et al. (2022) · Alzheimer s & Dementia · doi:10.1002/alz.12714 · Cited by 96
pySuStaIn: A Python implementation of the Subtype and Stage Inference algorithm
Aksman, L., Wijeratne, P. A., Oxtoby, N. P., Eshaghi, A., Shand, C., Altmann, A., Alexander, D. C., & Young, A. L. (2021) · SoftwareX · doi:10.1016/j.softx.2021.100811 · Cited by 95
The Role and Regulatory Mechanism of Hippo Signaling Components in the Neuronal System
Cheng, J., Wang, S., Dong, Y., & Yuan, Z. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00281 · Cited by 94
Cheng, Y., Lin, C., & Lane, H. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22052283 · Cited by 92
Cairns, N. J., Perrin, R. J., Franklin, E. E., Carter, D., Vincent, B., Xie, M., Bateman, R. J., Benzinger, T., Friedrichsen, K., Brooks, W. S., et al. (2015) · Neuropathology · doi:10.1111/neup.12205 · Cited by 86
Self-citationHerpes simplex virus type 1 and Alzheimer’s disease
Dobson, C. B., & Itzhaki, R. F. (1999) · Neurobiology of Aging · doi:10.1016/s0197-4580(99)00055-x · Cited by 86
Nigrostriatal Dysfunction in Familial Alzheimer's Disease-Linked APPswe/PS1ΔE9 Transgenic Mice
Perez, S. E., Lazarov, O., Koprich, J. B., Chen, E.-Y., Rodriguez-Menendez, V., Lipton, J. W., Sisodia, S. S., & Mufson, E. J. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.2773-05.2005 · Cited by 86
Integrating Gene and Protein Expression Reveals Perturbed Functional Networks in Alzheimer’s Disease
Canchi, S., Raao, B., Masliah, D., Rosenthal, S. B., Sasik, R., Fisch, K. M., De Jager, P. L., Bennett, D. A., & Rissman, R. A. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.06.073 · Cited by 84
Loss of serum IGF-I input to the brain as an early biomarker of disease onset in Alzheimer mice
Trueba-Sáiz, A., Cavada, C., Fernandez, A. M., Leon, T., González, D. A., Fortea Ormaechea, J., Lleó, A., Del Ser, T., Nuñez, A., & Torres-Aleman, I. (2013) · Translational Psychiatry · doi:10.1038/tp.2013.102 · Cited by 84
Kodam, P., Sai Swaroop, R., Pradhan, S. S., Sivaramakrishnan, V., & Vadrevu, R. (2023) · Scientific Reports · doi:10.1038/s41598-023-30892-6 · Cited by 82
Cordella, A., Krashia, P., Nobili, A., Pignataro, A., La Barbera, L., Viscomi, M. T., Valzania, A., Keller, F., Ammassari-Teule, M., Mercuri, N. B., et al. (2018) · Neurobiology of Disease · doi:10.1016/j.nbd.2018.05.006 · Cited by 82
Zandl‐Lang, M., Fanaee‐Danesh, E., Sun, Y., Albrecher, N. M., Gali, C. C., Čančar, I., Kober, A. C., Tam‐Amersdorfer, C., Stracke, A., Storck, S. E., et al. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2017.09.008 · Cited by 78
Wu, Q., Shaikh, M., Meymand, E. S., Zhang, B., Luk, K. C., Trojanowski, J. Q., & Lee, V. M. ‐. (2020) · Acta Neuropathologica · doi:10.1007/s00401-020-02227-6 · Cited by 76
Iacono, D., Resnick, S. M., O’Brien, R., Zonderman, A. B., An, Y., Pletnikova, O., Rudow, G., Crain, B., & Troncoso, J. C. (2014) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0000000000000052 · Cited by 73
14-3-3 protein in the CSF of patients with rapidly progressive dementia
Huang, N., Marie, S. K. N., LIVRAMENTO, J. A., Chammas, R. J., & Nitríni, R. (2003) · Neurology · doi:10.1212/01.wnl.0000078890.89473.ed · Cited by 72
Salehi, Z., Mashayekhi, F., & Naji, M. (2008) · BioFactors · doi:10.1002/biof.5520330202 · Cited by 71
Targeted metabolomics and medication classification data from participants in the ADNI1 cohort
St John-Williams, L., Blach, C., Toledo, J. B., Rotroff, D. M., Kim, S., Klavins, K., Baillie, R., Han, X., Mahmoudiandehkordi, S., Jack, J., et al. (2017) · Scientific Data · doi:10.1038/sdata.2017.140 · Cited by 71
Glial Fibrillary Acidic Protein in the Cerebrospinal Fluid of Patients with Dementia
Wallin, A., Blennow, K., & Rosengren, L. E. (1996) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000106891 · Cited by 69
Pathobiological Subtypes of Alzheimer Disease
Jellinger, K. A. (2020) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000508625 · Cited by 67
Applied machine learning in Alzheimer's disease research: omics, imaging, and clinical data
Li, Z., Jiang, X., Wang, Y., & Kim, Y. (2021) · Emerging Topics in Life Sciences · doi:10.1042/etls20210249 · Cited by 65
The Lewy body variant of Alzheimer disease
Hansen, L. A. (1997) · Journal of neural transmission. Supplementum · doi:10.1007/978-3-7091-6846-2_7 · Cited by 62
Hishimoto, A., Pletnikova, O., Lang, D. L., Troncoso, J. C., Egan, J. M., & Liu, Q.-R. (2019) · Alzheimer's Research & Therapy · doi:10.1186/s13195-019-0475-2 · Cited by 62
Wang, X., He, H., Xiong, X., Zhou, S., Wang, W., Feng, L., Han, R., & Xie, C. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.668491 · Cited by 61
Meta-Analysis of Serum Insulin-Like Growth Factor 1 in Alzheimer’s Disease
Ostrowski, P. P., Barszczyk, A., Forstenpointner, J., Zheng, W., & Feng, Z.-P. (2016) · PLOS ONE · doi:10.1371/journal.pone.0155733 · Cited by 60
Synaptic vesicle cycle and amyloid β: Biting the hand that feeds
Ovsepian, S. V., O'Leary, V. B., Zaborszky, L., Ntziachristos, V., & Dolly, J. O. (2018) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2018.01.011 · Cited by 57
The Dominantly Inherited Alzheimer Network (DIAN), Li, Z., Del-Aguila, J. L., Dube, U., Budde, J., Martinez, R., Black, K., Xiao, Q., Cairns, N. J., Dougherty, J. D., et al. (2018) · Genome Medicine · doi:10.1186/s13073-018-0551-4 · Cited by 56
Self-citationHwang, J., Estick, C. M., Ikonne, U. S., Butler, D., Pait, M. C., Elliott, L. H., Ruiz, S., Smith, K., Rentschler, K. M., Mundell, C., et al. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20184432 · Cited by 55
Chung, J., Das, A., Sun, X., Sobreira, D. R., Leung, Y. Y., Igartua, C., Mozaffari, S. V., Chou, Y., Thiagalingam, S., Mez, J., et al. (2022) · Alzheimer s & Dementia · doi:10.1002/alz.12719 · Cited by 53
Altered dopamine modulation of LTD-like plasticity in Alzheimer’s disease patients
Koch, G., Esposito, Z., Codecà, C., Mori, F., Kusayanagi, H., Monteleone, F., Lorenzo, F. D., Bernardi, G., & Martorana, A. (2010) · Clinical Neurophysiology · doi:10.1016/j.clinph.2010.10.033 · Cited by 50
Clark, C., Rabl, M., Dayon, L., & Popp, J. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.1065904 · Cited by 50
Ceyzériat, K., Gloria, Y., Tsartsalis, S., Fossey, C., Cailly, T., Fabis, F., Millet, P., & Tournier, B. B. (2021) · Brain Communications · doi:10.1093/braincomms/fcab029 · Cited by 47
Down‐regulation of glutamatergic terminals (VGLUT1) driven by Aβ in Alzheimer's disease
Rodriguez‐Perdigon, M., Tordera, R. M., Gil‐Bea, F. J., Gerenu, G., Ramirez, M. J., & Solas, M. (2016) · Hippocampus · doi:10.1002/hipo.22607 · Cited by 47
Zheng, J.-J., Li, W.-X., Liu, J.-Q., Guo, Y.-C., Wang, Q., Li, G.-H., Dai, S.-X., & Huang, J.-F. (2018) · Medicine · doi:10.1097/md.0000000000011343 · Cited by 45
Jin, T., Rehani, P., Ying, M., Huang, J., Liu, S., Roussos, P., & Wang, D. (2021) · Genome Medicine · doi:10.1186/s13073-021-00908-9 · Cited by 40
Nuutinen, T., Huuskonen, J., Suuronen, T., Ojala, J. O., Miettinen, R. A., & Salminen, A. (2006) · Neurochemistry International · doi:10.1016/j.neuint.2006.11.002 · Cited by 40
Sekiya, M., Wang, M., Fujisaki, N., Sakakibara, Y., Quan, X., Ehrlich, M. E., De Jager, P. L., Bennett, D. A., Schadt, E. E., Gandy, S., et al. (2018) · Genome Medicine · doi:10.1186/s13073-018-0530-9 · Cited by 38
Clusterin CSF levels in differential diagnosis of neurodegenerative disorders
Vranová, H. P., Hényková, E., Mareš, J., Kaiserová, M., Menšíková, K., Vaštík, M., Hluštík, P., Zapletalová, J., Strnad, M., Stejskal, D., et al. (2015) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2015.12.023 · Cited by 37
Metabolomic and lipidomic signatures in autosomal dominant and late‐onset Alzheimer's disease brains
Novotny, B. C., Fernandez, M. V., Wang, C., Budde, J. P., Bergmann, K., Eteleeb, A. M., Bradley, J., Webster, C., Ebl, C., Norton, J., et al. (2023) · Alzheimer's & Dementia · doi:10.1002/alz.12800 · Cited by 37
Self-citationNon‐coding variants in MYH11, FZD3, and SORCS3 are associated with dementia in women
Blue, E., Thornton, T. A., Kooperberg, C. L., Liu, S., Wactawski‐Wende, J., Manson, J. E., Kuller, L., Hayden, K. M., & Reiner, A. P. (2020) · Alzheimer s & Dementia · doi:10.1002/alz.12181 · Cited by 34
Gap Junctions in the Nervous System: Probing Functional Connections Using New Imaging Approaches
Dong, A., Liu, S., & Li, Y. (2018) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2018.00320 · Cited by 33
Galle, S. A., van der Spek, A., Drent, M. L., Brugts, M. P., Scherder, E. J. A., Janssen, J. A. M. J. L., Ikram, M. A., & van Duijn, C. M. (2019) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2019.00020 · Cited by 31
Chen, H., Eteleeb, A. M., Wang, C., Fernández, M. V., Budde, J., Bergmann, K., Norton, J. B., Wang, F., Ebl, C., Morris, J. C., et al. (2022) · Acta Neuropathologica Communications · doi:10.1186/s40478-022-01328-5 · Cited by 31
Self-citationClusterin: a multifaceted protein in the brain
Zhao, L., Moon, H.-J., & Herring, S. K. (2020) · Neural Regeneration Research · doi:10.4103/1673-5374.301013 · Cited by 26
Choi, M., Youn, H., Kim, D., Lee, S., Suh, S., Seong, J., Jeong, H., & Han, C. E. (2019) · PLoS ONE · doi:10.1371/journal.pone.0220739 · Cited by 25
Early increase of cerebrospinal fluid 14-3-3ζ protein in the alzheimer's disease continuum
Lu, Y. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.941927 · Cited by 18
Odom, G., Colaprico, A., Silva, T. C., Chen, X. S., & Wang, L. (2021) · Frontiers in Genetics · doi:10.3389/fgene.2021.783713 · Cited by 17
Xie, L., He, B., Varathan, P., Nho, K., Risacher, S. L., Saykin, A. J., Salama, P., & Yan, J. (2021) · Briefings in Bioinformatics · doi:10.1093/bib/bbab121 · Cited by 16
enrichR: Provides an R Interface to 'Enrichr'
Jawaid, W. (2017) · doi:10.32614/cran.package.enrichr · Cited by 14
Min, S., Li, Z.-C., Shieh, A. W., Giase, G., Bao, R., Zhang, C., Kuney, L., Kopp, R., Asif, H., Alliey-Rodriguez, N., et al. (2021) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2021.07.010 · Cited by 11
Patel, K. R., Zhu, K., Henrion, M., Beckmann, N. D., Moein, S., Alamprese, M. L., Allen, M., Wang, X., Chan, G., Pertel, T., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.06.09.143529 · Cited by 9
The landscape of metabolic brain alterations in Alzheimer’s diseasePreprint
Batra, R., Arnold, M., Wörheide, M. A., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.11.15.468698 · Cited by 8
The role of astrocytes in axon guidance during development and repair
Vickland, H., & Silver, J. (1997) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9781872748542.003.0010 · Cited by 5
Byrns, C. N., & Bonini, N. M. (2021) · Neuron · doi:10.1016/j.neuron.2020.12.015 · Cited by 5
Ou, Y. (2023) · Alzheimer s & Dementia · doi:10.1002/alz.073550 · Cited by 4
Li, Z., Del‐Aguila, J. L., Dube, U., et al. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/266296 · Cited by 3
Price (1999) · doi:10.1002/1531-8249(199903)45:3
Greber (1999) · doi:10.1002/(sici)1522-2683(19990101)20:4/5<928::aid-elps928>3.0.co;2-z
Research works printed but not linked: 8
- CF Lippa, 1999, Antibodies to α-synuclein detect Lewy bodies in many Down’s syndrome brains with Alzheimer’s disease., Ann Neurol, 45, 353, 10.1002/1531-8249(199903)45:3<353::AID-ANA11>3.0.CO;2-4 · doi:10.1002/1531-8249(199903)45:3<353::aid-ana11>3.0.co;2-4
- S. Andrews, 2010, FastQC: a quality control tool for high throughput sequence data., Babraham Bioinformatics, Babraham Institute, Cambridge, United Kingdom
- Picard Toolkit., 2019, Broad Institute, GitHub Repository.
- S Lê, 2008, FactoMineR: an R package for multivariate analysis, J Stat Softw, 25, 1
- T Hastie, 2018, impute: impute: Imputation for microarray data., R package version.
- Q Mo, 2013, iClusterPlus: integrative clustering of multiple genomic data sets
- T. Therneau, 2020, A Package for Survival Analysis in R., R package version 3.2–3
- A. Eklund, 2017, surviplot: Draw Survival Curves with Number-at-Risk., R package version 1.1.1
Cited by
Ren, F., Wei, J., Chen, Q., Hu, M., Yu, L., Mi, J., Zhou, X., Qin, D., Wu, J., & Wu, A. (2025) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2025.07.030 · Cited by 97
Hein, Z. M., Karikalan, B., Gopalakrishna, P. K., Dhevi, K., Alkatiri, A., Hussan, F., Mohd Moklas, M. A., Jagadeesan, S., Che Ramli, M. D., Che Mohd Nassir, C. M. N., et al. (2026) · Molecular Neurobiology · doi:10.1007/s12035-025-05602-0 · Cited by 43
The mTOR pathway: a common link between Alzheimer's disease and Down Syndrome
Wohlfert, A. J., Phares, J., & Granholm, A.-C. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13206183 · Cited by 6
“A multi-omics study reported distinct molecular profiles in AD cases associated with decreased cognitive function, early onset/death, and dysregulated neuronal/synaptic pathways [113].”
BackgroundSchneegans, E., Fancy, N., Thomas, M., Adair, E., Willumsen, N., Papageorgopoulou, M., Chau, V., Cheung, T. K. D., Muirhead, R. C. J., Whitwell, H., et al. (2024) · doi:10.1101/2024.08.27.24312641 · Cited by 2
Synaptic Plasticity—Intrinsic Excitability and Antidepressant Discovery
Tanaka, M. (2026) · Biomedicines · doi:10.3390/biomedicines14061265
Metadata
- Authors
- Eteleeb, A. M., Novotny, B. C., Tarraga, C. S., Sohn, C., Dhungel, E., Brase, L., Nallapu, A., Buss, J., Farias, F., Bergmann, K., Bradley, J., Norton, J., Gentsch, J., Wang, F., Davis, A. A., Morris, J. C., Karch, C. M., Perrin, R. J., Benitez, B. A., & Harari, O.
- Affiliations
- Washington University in St. Louis (US)
- University of North Carolina at Charlotte (US)
- Corresponding author
- Eteleeb, Abdallah M.
- Novotny, Brenna C.
- Sohn, Christopher
- Dhungel, Eliza
- Brase, Logan
- Nallapu, Aasritha
- Buss, Jared
- Farias, Fabiana
- Bergmann, Kristy
- Bradley, Joseph
- Norton, Joanne
- Gentsch, Jen
- Wang, Fengxian
- Davis, Albert A.
- Morris, John C.
- Karch, Celeste M.
- Perrin, Richard J.
- Harari, Oscar
- ORCID
- Venue
- PLOS Biology
- Publisher
- Public Library of Science (PLoS)
- Published
- 2024-04-30
- Volume
- 22
- Issue
- 4
- Pages
- e3002607
- ISSN
- 1544-9173 (ISSN-L)
- 1545-7885
- PMC
- PMC11086901
- OpenAlex
- W4396506788
- Cited by
- 64
- References
- 187
- Citations by year
- 2026: 37 · 2025: 24 · 2024: 3
- FWCI
- 18.07
- Type
- journal article
- Language
- en
- Update notices
- new_version (2024-05-10)
- Open access
- gold
- doi.org
- Licence
- Locations
- PLoS Biology (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Digital Commons@Becker (Washington University School of Medicine) (submittedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Funders
- National Institute on Aging (P30AG066444, P01AG003991, P01AG026276, R01AG057777, R01AG074012, U01AG072464, K01AG046374, R56AG067764, K25AG083057)
- National Institute of Neurological Disorders and Stroke (R01NS118146, R21NS127211)
- Chan Zuckerberg Initiative
- Beth Israel Deaconess Medical Center (2023 Translational Hub Spark Grant Award)
- Archer Foundation
- Knight Alzheimer Disease Research Center (P30 AG066444)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- Alzheimer's disease, molecular heterogeneity, transcriptomics, proteomics, metabolomics, lipidomics, astrocyte activation, synapse-related genes, mTOR signaling, endocytosis, phagosome, single-nucleus RNA sequencing, cell types, cerebrospinal fluid biomarkers, disease progression, cognitive decline, survival
- MeSH terms
- Machine Learning, Multiomics, Aged, Alzheimer Disease, Animals, Brain, Disease Models, Animal, Female, Humans, Male, Biomarkers, Disease Progression, Proteomics, Mice, Metabolomics, Transcriptome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.